BridgeBio Pharma Inc (BBIO)
23.44
+0.20
(+0.86%)
USD |
NASDAQ |
Nov 22, 16:00
23.44
0.00 (0.00%)
After-Hours: 18:11
BridgeBio Pharma Total Liabilities (Quarterly): 1.883B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.883B |
| June 30, 2024 | 1.876B |
| March 31, 2024 | 1.886B |
| December 31, 2023 | 1.889B |
| September 30, 2023 | 1.849B |
| June 30, 2023 | 1.853B |
| March 31, 2023 | 1.839B |
| December 31, 2022 | 1.868B |
| September 30, 2022 | 1.859B |
| June 30, 2022 | 1.877B |
| March 31, 2022 | 1.854B |
| December 31, 2021 | 1.878B |
| Date | Value |
|---|---|
| September 30, 2021 | 1.517B |
| June 30, 2021 | 1.537B |
| March 31, 2021 | 1.481B |
| December 31, 2020 | 595.70M |
| September 30, 2020 | 569.31M |
| June 30, 2020 | 577.72M |
| March 31, 2020 | 537.73M |
| December 31, 2019 | 155.70M |
| September 30, 2019 | 116.26M |
| June 30, 2019 | 593.09M |
| March 31, 2019 | 90.71M |
| December 31, 2018 | 87.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
155.70M
Minimum
Dec 2019
1.889B
Maximum
Dec 2023
1.469B
Average
1.851B
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 4.173B |
| Pfizer Inc | 126.92B |
| Vertex Pharmaceuticals Inc | 6.609B |
| PTC Therapeutics Inc | 2.897B |
| Bristol-Myers Squibb Co | 76.47B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 664.98M |
| Shareholders Equity (Quarterly) | -1.230B |
| Debt to Equity Ratio | -1.398 |
| Current Ratio | 3.193 |
| Net Debt Paydown Yield | -0.00% |